CONTOUR MICROPARTICLES OF PVA FOR EMBOLIZATION - Registered in Anvisa under the number 10341350316. Lots - Attached List. 의 안전성 경고

Agência Nacional de Vigilância Sanitária (ANVISA)에 따르면, 해당 안전성 경고 는 Brazil 에서 Boston Scientific do Brasil Ltda. 에 의해 제조된 제품과 관련되어 있습니다.

이것은 무엇인가요?

안전성 경고는 의료기기 제품과 관련된 중요한 정보와 권고사항을 담고 있습니다. 물론 안전성 경고가 배포되었다고 해서 해당 제품이 무조건 안전하지 않은 제품이라는 것은 아닙니다. 보건의료업계 종사자와 의료기기 사용자들에게 배포되는 안전성 경고에는 회수(recall)도 포함될 수 있습니다. 제조사가 안전성 경고를 작성하기도 하지만, 보건당국에서 작성하는 경우도 있습니다.

데이터에 대해 더 자세히 알아보기 여기
  • 사례 유형
    Safety alert
  • 사례 ID
    983
  • 날짜
    2009-09-22
  • 사례 국가
  • 사례 출처
    ANVISA
  • 사례 출처 URL
  • 비고 / 경고
    Brazilian data is current through June 2018. All of the data comes from Anvisa, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of data from the U.S. and Brazil.
  • 데이터 추가 비고
    Attached to this notification is a complete listing of all product codes within the scope of this Voluntary Collection. The company is aware that some customers can often remove the product from their carton (secondary packaging) and store it on the stock shelves only in their primary packaging (pouch). If this is a practice in your unit, it is very important that you use the attached product table very carefully, and consider both the UPN code on the primary packaging (pouch) and the secondary packaging (box) when looking for the affected product / product of this voluntary recall, since the UPN numbers on the internal and external labels are different. The product information listed on your Verification and Traceability Response Form (attached in this alert) provides only the UPN codes of the secondary packaging (carton). Anvisa is following this action.
  • 원인
    The company reports that there may be a possibility of compromising the sterile barrier in some packaging. all affected products are packed in a bottle and subsequently in a pouch. the company concluded that the sterile pouch barrier containing the bottle may be ruptured. disruption of sterilization can lead to contamination, which may pose a risk of adverse effects to the patient's health, including, in more extreme cases, septicemia.
  • 조치
    The actions recommended to users of the product are as follows: (1) Immediately stop the use of products listed in the attached list; (2) Locate products with the affected models / batches in your inventory and segregate them in a safe place. (3) Complete and return the account verification and traceability response form to Boston Scientific do Brasil Ltda. - A / C Caroline Yin - Fax: (011) 5502-8510; (4) Pack, identify the box with affected products and request collection by calling (011) 5502-8583.

Manufacturer